Literature DB >> 29885835

HIF-1α induces immune escape of prostate cancer by regulating NCR1/NKp46 signaling through miR-224.

Chao-Hao Chen1, Shao-Xun Li2, Lu-Xia Xiang2, Hai-Qi Mu1, Shuai-Bin Wang1, Kai-Yuan Yu3.   

Abstract

BACKGROUND: Metastasis of prostate cancer (PCa) is largely affected by natural killer (NK) cells. This study aimed to clarify the mechanisms underlying tumor cells escaping from NK cells mediated by HIF-1α.
METHODS: MiR-224 expression in lymphocytes and HIF-1α protein level in NK cells were determined by qRT-PCR and western blot, respectively. The amount of NKp46+ NK cells was detected with flow cytometry. The IFN-γ level was examined by enzyme linked immunosorbent assay (ELISA). NK cells were tested for cytolytic activity with a Non-Radioactive Cytotoxicity Assay, and treated with oxygenglucose deprivation (OGD) for hypoxia simulation. Interaction between miR-224 and NCR1 was evaluated with dual luciferase reporter assay.
RESULTS: MiR-224 was down-regulated in lymphocytes isolated from prostate cancer tissues (n = 10). Overexpression of miR-224 protected prostate cancer from NK cells. HIF-1α increased miR-224 to inhibit the killing capability of NK cells on prostate cancer. MiR-224 controlled the expression of NCR1. Overexpression of miR-224 protected prostate cancer from NK cells through NCR1/NKp46 signaling. Suppression of HIF-1α enhanced the cytotoxicity of NK cells on prostate cancer via miR-224/NCR1 pathway.
CONCLUSION: HIF-1α inhibits NCR1/NKp46 pathway through up-regulating miR-224, which affects the killing capability of NK cells on prostate cancer, thus inducing immune escape of tumor cells.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HIF-1α; NCR1/NKp46; Natural killer cells; Prostate cancer; miR-224

Mesh:

Substances:

Year:  2018        PMID: 29885835     DOI: 10.1016/j.bbrc.2018.06.007

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

Review 1.  Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape.

Authors:  Qinghua Wu; Li You; Eugenie Nepovimova; Zbynek Heger; Wenda Wu; Kamil Kuca; Vojtech Adam
Journal:  J Hematol Oncol       Date:  2022-06-03       Impact factor: 23.168

2.  Identification of ISG15 and ZFP36 as novel hypoxia- and immune-related gene signatures contributing to a new perspective for the treatment of prostate cancer by bioinformatics and experimental verification.

Authors:  Fang Lyu; Yunxue Li; Zhecheng Yan; Qingliu He; Lulin Cheng; Pu Zhang; Bing Liu; Chunyu Liu; Yarong Song; Yifei Xing
Journal:  J Transl Med       Date:  2022-05-10       Impact factor: 8.440

Review 3.  The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.

Authors:  Jan Korbecki; Klaudyna Kojder; Patrycja Kapczuk; Patrycja Kupnicka; Barbara Gawrońska-Szklarz; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2021-01-15       Impact factor: 5.923

4.  Effects of miR-103a-3p Targeted Regulation of TRIM66 Axis on Docetaxel Resistance and Glycolysis in Prostate Cancer Cells.

Authors:  Qiang Yi; Junfeng Wei; Yangzhou Li
Journal:  Front Genet       Date:  2022-02-08       Impact factor: 4.599

5.  Roxadustat Attenuates the Disruption of Epithelial Tight Junction in Caco2 Cells and a Rat Model of CKD Through MicroRNA-223.

Authors:  Ning Qu; Lei Chen; Shanshan Liang; Meng Wei; Lingshuang Sun; Quan He; Jinhong Xue; Meng Wang; Kehui Shi; Hongli Jiang; Hua Liu
Journal:  Front Med (Lausanne)       Date:  2022-04-13

Review 6.  The Multifaceted Role of STAT3 in NK-Cell Tumor Surveillance.

Authors:  Agnieszka Witalisz-Siepracka; Klara Klein; Bernhard Zdársky; Dagmar Stoiber
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

Review 7.  Could Harnessing Natural Killer Cell Activity Be a Promising Therapy for Prostate Cancer?

Authors:  Jennifer Wu
Journal:  Crit Rev Immunol       Date:  2021       Impact factor: 2.214

8.  Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.

Authors:  Yao Cui; Hai-Feng Xu; Ming-Yue Liu; Yu-Jie Xu; Jun-Chuang He; Yun Zhou; Shun-Dong Cang
Journal:  World J Gastroenterol       Date:  2019-04-21       Impact factor: 5.742

9.  TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.

Authors:  Wei Chen; Li-Na He; Yong Liang; Xiang Zeng; Cui-Ping Wu; Ming-Qiang Su; Yang Cheng; Jian-Hui Liu
Journal:  Mol Med Rep       Date:  2020-10-21       Impact factor: 2.952

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.